*Yukino Takenouchi¹, Kana Onodera¹, Yoshiko Iizuka², Keisuke Yoshikawa³, Tadahiro Suenaga¹, Etsuro Ohta^1,2,4 (1. Program in Cellular Immunology, Graduate School of Medical Science, Kitasato University, Kanagawa, Japan, 2. Regenerative Medicine and Cell Design Research faculty, Kitasato University School of Allied Health Sciences, Kanagawa, Japan, 3. Department of Pharmacology, Faculty of Medicine, Saitama Medical University, Saitama, Japan, 4. Division of Blood Transfusion and Transplantation, Kitasato University School of Health Sciences, Niigata, Japan)

*Chaitra Sathyaprakash¹, China Tatebori¹, Reiko Terada¹, Katsuhiko Kunitake¹, Daisuke Kawauchi², Momoko Watanabe³, Mariko Taniguchi-Ikeda⁴, Hideya Sakaguchi⁵, Yoshitsugu Aoki¹ (1. Department of Molecular Therapy, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 2. Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 3. Department of Anatomy & Neurobiology, Sue & Bill Gross Stem Cell Research Center, School of Medicine, University of California, Irvine, Irvine, CA, USA, 4. Department of Clinical Genetics, Fujita Health University Hospital, Toyoake, Aichi, Japan, 5. BDR-Otsuka Pharmaceutical Collaboration Center, RIKEN Center for Biosystems Dynamics Research, Kobe, Japan)